Blood concentrations of Nf‐L and Nf‐H proteins in C9+ve ALS patients were comparable to those detected in ALS‐S and reduced compared to the ALS‐F subgroup (Fig. 2A and B; p = 0.002 and p = 0.027, respectively). This evidence concerns the gene C9 and amyotrophic lateral sclerosis.